Articles published by NeuraLight

Clinical Trial Results Show NeuraLight Biomarkers Predict Functional Decline in People With Parkinson’s Disease

Today 8:00 EDT

From NeuraLight

Via Business Wire

NeuraLight Wins Fast Company’s World Changing Ideas Award for Its Innovation in Brain Function Measurement

July 14, 2026

From NeuraLight

Via Business Wire

NeuraLight Biomarkers Reveal What Parkinson's Gold-Standard Measurement Scale Misses in a Study Led by the Scale's Own Developers

June 03, 2026

From NeuraLight

Via Business Wire

Kariya and NeuraLight Partner to Measure How Next-Generation GLP-1 Therapies Impact the Brain

May 14, 2026

From NeuraLight

Via Business Wire

NeuraLight at AD/PD 2026: Revealing Next-Generation Brain-Function Biomarker Readouts Powering a First-of-its-Kind Neuroprotection Signal in Drug Trials

February 26, 2026

From NeuraLight

Via Business Wire

NeuraLight and Teitur Trophics Announce Collaboration to Use Precision Biomarkers in TT-P34 Parkinson’s Disease Clinical Trial

January 21, 2026

From NeuraLight

Via Business Wire

NeuraLight Reaches Key Milestone with Completion of International Multicenter Parkinson’s Clinical Trial

January 07, 2026

From NeuraLight

Via Business Wire

NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology

December 13, 2025

From NeuraLight

Via Business Wire

NeuraLight and CHDI Foundation Collaborate to Develop Precision Eye Movement Biomarkers for Huntington's Disease

September 09, 2025

From NeuraLight

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.